Q3 2023

Filed Nov 7, 2023 · 10-Q · 38 days after period end · 0000877860-23-000108

Q3 2023 · 10-Q

Revenue

$12.37M

+2.9% vs Q3 2022

Net Income

$29.35M

−14.9% vs Q3 2022

EPS Diluted

$0.68

−12.8% vs Q3 2022

Operating Cash Flowderived$49,703,000+14.2%

Same quarter

Metric	Q3 2023	Q3 2022	Q3 2021	Q3 2020
Revenue	$12.37M	$12.01M	$0.00	$84.30M
Net Income	$29.35M	$34.47M	$30.81M	$42.60M
EPS Diluted	$0.68	$0.78	$0.67	$0.95

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR